Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles-Reference-Cited by-同舟云学术

Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles

Published:2020-01 Issue: Volume:51 Page:102585
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Malas Tareq B.,Leonhard Wouter N.,Bange Hester,Granchi Zoraide,Hettne Kristina M.,Van Westen Gerard J.P.,Price Leo S.,'t Hoen Peter A.C.,Peters Dorien J.M.

Funder

European Union's Seventh Framework Program

Research Executive Agency

Dutch Technology Foundation Stichting Technische Wetenschappen Project

Dutch Kidney Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference65 articles.

1. Can you teach old drugs new tricks?;Nosengo;Nature,2016

2. Exploiting drug-disease relationships for computational drug repositioning;Dudley;Brief Bioinform,2011

3. An information-intensive approach to the molecular pharmacology of cancer;Weinstein;Science,1997

4. Old drugs, new tricks: using genetically sensitized yeast to reveal drug targets;Hughes;Cell,2004

5. In vitro 3d phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease;Booij;J Mol Cell Biol,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming of Energy Metabolism in Human PKD1 Polycystic Kidney Disease: A Systems Biology Analysis;International Journal of Molecular Sciences;2024-06-29

2. Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease;Frontiers in Pharmacology;2024-05-23

3. Transcriptomic profiling of Polycystic Kidney Disease identifies paracrine factors in the early cyst microenvironment;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

4. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD;Cell Reports;2023-12

5. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion;Molecular Medicine;2023-05-22